USE OF VOBENZYME IN COMPLEX THERAPY OF PATIENTS WITH CHRONIC PROSTATITIS

Abstract

THE AIM of the work was to determine the place of the systemic enzymotherapy drug Vobenzyme in complex treatment of patients with chronic prostatitis. PATIENTS AND METHODS. Under examination there were 110 patients with chronic prostatitis in phase of active inflammation; 70 of them were given Vobenzyme in addition to traditional antibacterial and antiinflammatory therapy and 40 patients were treated by traditional antibacterial therapy and made up the group of comparison. The dose of Vobenzyme was 500 mg three times a day during a month, followed by two repeated courses with a one month interval. Immune status, blood flow in the prostate by rheography, clinical manifestations of the disease were studied in all the patients. Laboratory investigation of the prostate secretion (or ejaculate) were made. RESULTS. In patients given Vobenzyme in complex treatment immunological indices were normalized, organic blood flow was considerably improved, analyses of the prostate secretion or ejaculate were also normalized. CONCLUSION. The data obtained allow to recommend inclusion of Vobenzyme as a means of systemic enzymotherapy in the complex treatment of patients with chronic prostatitis.